Freelance- Translators/Linguists, English into Spanish (Latin America) at IQVIA

Melbourne, Victoria, Australia

Apply Now

Not SpecifiedCompensation

Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level

Full TimeJob Type

UnknownVisa

Life SciencesIndustries

Requirements

Native fluency in target language (Spanish for Latin America) – spoken and written
Fluency in source language (English) – spoken and written
At least 1 year of experience translating, reviewing, and editing life sciences content including clinical trial documents (must be clearly outlined in CV with document types)
A university degree in translation or linguistics and at least 2 years of translation experience OR no university degree and at least 5 years of translation experience
Ability to work according to tight deadlines and independently
Experience with translation management systems and CAT tools
Prior experience as a translator with a translation and localisation company (desirable, not essential)

Responsibilities

Translate, review, and edit life sciences content from English into Spanish (Latin America), including clinical trial documents
Deliver content in target languages and markets effectively and in a timely fashion

Skills

English to Spanish Translation

Latin American Spanish

Life Sciences Translation

Clinical Trial Documents

CAT Tools

Translation Management Systems

Translation Reviewing

Translation Editing

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free